| Structure |
Chemical Name |
CAS |
MF |
 |
5-chloro-N-(4-nitrophenyl)pentanamide |
1039914-85-6 |
C11H13ClN2O3 |
 |
Apixaban Impurity 16 |
1619934-76-7 |
C31H37N5O6 |
 |
Apixaban Impurity 22 |
1449510-64-8 |
C25H26ClN5O4 |
 |
Apixaban Impurity 31 |
2458079-10-0 |
C27H30N4O6 |
 |
Apixaban Impurity 38 |
|
|
 |
Afatinib impurity 41 |
69169-63-7 |
C5H9NO2 |
 |
Apixaban Impurity 18 |
473927-65-0 |
C20H17IN4O3 |
|
|
Avatrombopag Impurity 56 |
|
|
 |
Apixaban Impurity 8 |
1777781-49-3 |
C24H23N5O4 |
 |
1-(4-NITRO-PHENYL)-PIPERIDIN-2-ONE |
39257-91-5 |
C5H10O2S |
 |
ethyl (E)-2-(2-(4-methoxyphenyl)hydrazono)propanoate |
4792-57-8 |
C12H16N2O3 |
 |
Apixaban Amino Acid Impurity |
2206825-87-6 |
C25H27N5O5 |
 |
Apixaban Impurity 52 |
1620494-31-6 |
C31H29N5O4 |
![Methyl 2-oxo-3-((2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl)Methyl)-2,3-dihydro-1H-benzo[d]iMidazole-4-carboxylate](/CAS/20130318/GIF/CB02611251.gif) |
Methyl 2-oxo-3-((2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl)Methyl)-2,3-dihydro-1H-benzo[d]iMidazole-4-carboxylate |
1403474-78-1 |
C24H18N4O5 |
 |
Azilsartan iMpurity |
1604812-35-2 |
C35H28N4O11 |
 |
Azilsartan iMpurity N |
2244031-86-3 |
C22H17N3O4 |
|
|
AtracuriuM Besylate IMpurity D Iodide (Mixture of DiastereoMers) |
|
|
|
|
AzithroMycin IMpurity D |
|
|
![1-[[2'-(AMinoiMinoMethyl)[1,1'-biphenyl]-4-yl]Methyl]-2-ethoxy-1H-benziMidazole-7-carboxylic Acid](/CAS/20150408/GIF/1442400-65-8.gif) |
1-[[2'-(AMinoiMinoMethyl)[1,1'-biphenyl]-4-yl]Methyl]-2-ethoxy-1H-benziMidazole-7-carboxylic Acid |
1442400-65-8 |
C24H22N4O3 |
 |
エリスロマイシンA 6,9-イミノエーテル |
99290-97-8 |
C37H66N2O12 |
|
|
Atracurium Impurity R |
|
|
|
|
Atracurium Impurity 28 |
|
|
|
|
Aprepitant impurity 1 |
|
|
![(Z)-Methyl 3-((2'-(N'-hydroxycarbaMiMidoyl)biphenyl-4-yl)Methyl)-2-oxo-2,3-dihydro-1H-benzo[d]iMidazole-4-carboxylate](/CAS/20130318/GIF/CB12611218.gif) |
(Z)-Methyl 3-((2'-(N'-hydroxycarbaMiMidoyl)biphenyl-4-yl)Methyl)-2-oxo-2,3-dihydro-1H-benzo[d]iMidazole-4-carboxylate |
1499167-72-4 |
C23H20N4O4 |
![2-エトキシ-1-((2'-(5-オキソ-2,5-ジヒドロ-1,2,4-オキサジアゾール-3-イル)-[1,1'-ビフェニル]-4-イル)メチル)-1H-ベンゾ[D]イミダゾール-7-カルボン酸エチル](/CAS/GIF/1403474-70-3.gif) |
2-エトキシ-1-((2'-(5-オキソ-2,5-ジヒドロ-1,2,4-オキサジアゾール-3-イル)-[1,1'-ビフェニル]-4-イル)メチル)-1H-ベンゾ[D]イミダゾール-7-カルボン酸エチル |
1403474-70-3 |
C27H24N4O5 |
|
|
AtracuriuM IMpurity K (Mixture of cis, trans, cis, cis(K1 & K2), tans, trans IsoMer) |
|
|
|
|
Atracurium Impurity E |
|
|
 |
Azilsartan Impurity |
1863930-34-0 |
C23H23N3O3 |
 |
Chidamide-13C7 |
1348337-81-4 |
C24H18N4O4 |
|
|
Atracurium Impurity M |
|
|
|
|
Atracurium Impurity 27 |
|
|
|
|
Apremilast Impurity TNB |
|
|
|
|
Atracurium Impurity N |
|
|
|
|
Atracurium impurity O drops |
|
|
![(Z)-2-ethoxy-3-((2'-(N'-hydroxycarbaMiMidoyl)biphenyl-4-yl)Methyl)-3H-benzo[d]iMidazole-4-carboxylic acid](/CAS/20130318/GIF/CB22611215.gif) |
(Z)-2-ethoxy-3-((2'-(N'-hydroxycarbaMiMidoyl)biphenyl-4-yl)Methyl)-3H-benzo[d]iMidazole-4-carboxylic acid |
1397836-49-5 |
C24H22N4O4 |
 |
AzithroMycin iMpurity |
194809-66-0 |
C37H69BN2O13 |
|
|
AtracuriuM IMpurity G (R-Laudanosine) |
|
|
 |
Azilsartan Impurity |
1675221-59-6 |
C25H22N2O5 |
|
|
Apremilast Impurity QY |
|
|
 |
アジスロマイシンB |
307974-61-4 |
C38H72N2O11 |
 |
N-エチル-N-ニトロソ-2-プロパンアミン |
16339-04-1 |
C5H12N2O |
|
|
デクラジノシルアジスロマイシン |
|
|
 |
Methyl 3-aMino-2-((2'-carbaMoylbiphenyl-4-yl)MethylaMino)benzoate |
147404-75-9 |
C22H21N3O3 |
 |
Azilsartan iMpurity O |
2171316-29-1 |
C23H19N3O4 |
|
|
AzithroMycin IMpurity K |
|
|
 |
O-Desethyl Azilsartan |
1442400-68-1 |
C23H16N4O5 |
 |
Apremilast Impurity FA |
2077897-94-8 |
C21H22N2O7S |
|
|
Atracurium Impurity S |
|
|
|
|
Atracurium Impurity 29 |
|
|
|
|
Atracurium Impurity 32 |
|
|
 |
1449029-77-9 |
1449029-77-9 |
C29H26N4O7 |
|
|
Azilsartan Impurity 107 |
|
|
 |
レキシスロマイシン |
53066-26-5 |
C38H70N2O13 |
|
|
Azilsartan iMpurity G |
|
|
|
|
Atracurium Impurity F |
|
|
 |
Apremilast Impurity 15 |
2096492-41-8 |
C22H26N2O8S |
|
|
Atracurium Impurity O |
|
|
|
|
Atracurium Impurity 4 |
|
|
|
|
Atracurium Impurity P |
|
|
|
|
Atracurium Impurity U |
|
|
 |
Azilsartan Impurity 11 |
91526-16-8 |
C12H12O6S |
|
|
Atracurium Impurity G Complete Set |
|
|
![2-(2-carboxyethyl)-1-[(3,4-dimethoxyphenyl)methyl]-,1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-isoquinolinium benzenesulfonate](/CAS/GIF/1075727-06-8.gif) |
2-(2-carboxyethyl)-1-[(3,4-dimethoxyphenyl)methyl]-,1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-isoquinolinium benzenesulfonate |
1075727-06-8 |
C30H37NO9S |
|
|
AzithroMycin iMpurity R |
|
|
|
|
AtracuriuM IMpurity H (Mixture of cis, trans(H1), cis, cis(H2)
tans, trans IsoMer) |
1248429-33-5 |
|
|
|
Atracurium Impurity B |
87046-74-0 |
|
|
|
Atracurium Impurity 2 |
|
|
 |
Atracurium Impurity 25 |
86682-55-5 |
C20H25NO5 |
|
|
Apremilast Impurity SJM |
|
|
 |
Atracurium Impurity 15 Iodide（Cisatracurium Besilate EP Impurity O Iodide） |
155913-31-8 |
C38H49NO11S |
|
|
Apremilast ImpurityTNN |
|
|
 |
trans N-Benzyl Paroxetine |
105813-14-7 |
C26H26FNO3 |
|
|
Lasmiditan Impurity 10 |
|
|
|
|
Nilotinib N-Oxide Impurity 3 |
|
|
|
|
Pemetrexed Impurity 51 |
|
|
|
|
6-((S)-7-amino-5-azaspiro[2.4]heptan-5-yl)-8-chloro-7-fluoro-1-((1R,2S)-2-fluorocyclopropyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
|
|
 |
(S)-タムスロシン塩酸塩 |
106463-19-8 |
C20H29ClN2O5S |
 |
2,2'-Bisnalmefene |
176220-84-1 |
C42H48N2O6 |
 |
4-Desmethoxypropoxyl-4-chloro Rabeprazole |
168167-42-8 |
C14H12ClN3OS |
![N-メチル-2-[4-[(Z)-1-(4-ヒドロキシフェニル)-2-フェニル-1-ブテニル]フェノキシ]エタンアミン](/CAS/GIF/110025-28-0.gif) |
N-メチル-2-[4-[(Z)-1-(4-ヒドロキシフェニル)-2-フェニル-1-ブテニル]フェノキシ]エタンアミン |
110025-28-0 |
C25H27NO2 |
 |
Rebeprazole sulfone N-oxide |
924663-37-6 |
C18H21N3O5S |
 |
3,5-ジヨード-4-(3,5-ジヨード-4-ヒドロキシフェノキシ)ベンゼン酢酸 |
67-30-1 |
C14H8I4O4 |
 |
N-(スルホオキシ)-4-メトキシ-1H-インドール-3-アセトイミド酸O-(β-D-グルコピラノシルチオ) |
83327-21-3 |
C17H22N2O10S2 |
 |
4-methylsulfinylbenzoate |
33963-58-5 |
C8H8O3S |
 |
AtracuriuM IMpurity D2 (cis-Quaternary Alcohol) |
1100676-16-1 |
C35H47NO10S |
|
|
AzithroMycin IMpurity O |
|
|
 |
AtracuriuM IMpurity V |
1075726-86-1 |
C25H34INO6 |
 |
5,6-Dehydro-Tigecycline |
1633815-62-9 |
C29H37N5O8 |
![2,3,5,6-tetradeuterio-4-[5-[4-(hydroxymethyl)phenyl]-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide](/CAS/20180601/GIF/1276524-56-1.gif) |
2,3,5,6-tetradeuterio-4-[5-[4-(hydroxymethyl)phenyl]-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide |
1276524-56-1 |
C17H10D4F3N3O3S |
 |
1,1-ジフェニル-1-プロパノール |
5180-33-6 |
C15H16O |
 |
(R)-De(trifluoromethyl) Fluoxetine Hydrochloride |
1212215-97-8 |
C16H20ClNO |
![(1R,5S)-1-phenyl-3-oxabicyclo[3.1.0]hexan-2-one](/CAS/20180601/GIF/96847-52-8.gif) |
(1R,5S)-1-phenyl-3-oxabicyclo[3.1.0]hexan-2-one |
96847-52-8 |
C11H10O2 |
![12-ethyl-8-methyl-9-oxo-7-propionyl-9,11-dihydroindolizino[1,2-b]quinolin-2-yl [1,4'-bipiperidine]-1'-carboxylate](/CAS/20180703/GIF/176515-52-9.gif) |
12-ethyl-8-methyl-9-oxo-7-propionyl-9,11-dihydroindolizino[1,2-b]quinolin-2-yl [1,4'-bipiperidine]-1'-carboxylate |
176515-52-9 |
C32H38N4O4 |
 |
4-amino-5-chloro-N-(1-propylpiperidin-4-yl)-2,3-dihydrobenzofuran-7-carboxamide |
|
C17H24ClN3O2 |
|
|
Ceftazidime Impurity D |
|
|
|
|
Ceftazidime Sulfoxide Impurity |
|
|
|
|
Tofacitinib Impurity Y |
|
|
 |
5-amino-6-chloro-2-(propylthio)pyrimidin-4-ol |
|
C7H10ClN3OS |
|
|
Labetalol EP impurity G |
|
|
 |
2-(2-NITROPHENYL)ETHANAMINE |
33100-15-1 |
C8H10N2O2 |